We determined that a pigeon cytochrome c-derived peptide, p43-58, possesses two anchor residues, 46 and 54, for binding with the I-A b molecule that are compatible to the position 1 (P1) and position 9 (P9) of the core region in the major histocompatibility complex (MHC) class II binding peptides, respectively. In the present study to analyze each binding site between P1 and P9 of p43-58 to either I-A b or T cell antigen receptor (TCR), we investigated T cell responses to a series of peptides (P2K, P3K, P4K, P5K, P6K, P7K, and P8E) that sequentially substituted charged amino acid residues for the residues at P2 to P8 of p43-58. T cells from C57BL͞10 (I-A b ) mice immunized with P4K or P6K did not mount appreciable proliferative responses to the immunogens, but those primed with other peptides (P2K, P3K, P5K, P7K, and P8E) showed substantial responses in an immunogenspecific manner. It was demonstrated by binding studies that P1 and P9 functioned as main anchors and P4 and P6 functioned as secondary anchors to I-A b . Analyses of V usage of T cell lines specific for these analogs suggested that P8 interacts with the complementarity-determining region 1 (CDR1)͞CDR2 of the TCR  chain. Furthermore, sequencing of the TCR on T cell hybridomas specific for these analogs indicated that P5 interacts with the CDR3 of the TCR  chain. The present findings are consistent with the threedimensional structure of the trimolecular complex that has been reported for TCR͞peptide͞MHC class I molecules.Formation of a trimolecular complex among T cell antigen receptor (TCR), major histocompatibility complex (MHC) molecule, and peptide antigen (Ag) is essential for T cell activation (1, 2). Recently, Garcia et al. (3) and Garboczi et al. (4) crystallized 2C TCR-K b -dEV8 and TCR-HLA-A2-Tax peptide, respectively. These crystallized trimolecular complexes were shown to possess similar structures. The long dimensions of the TCR and MHC class I peptide binding surfaces are tilted approximately 20°to 30°toward the diagonal. These restrictions may place the CDR1 and CDR2 of the TCR  chain over the 1 and ␣1 helices of the MHC class I molecule, respectively. This orientation of TCR to MHC class I peptide resembles the model of TCR-MHC class II complex proposed by Sant'Angelo et al. (5), in which the complementarity-determining region (CDR)1 and CDR2 of the TCR ␣ chain lie over the N-terminal region of the peptide, CDR3 of the TCR ␣ chain interacts with the central position (P) 5 of the peptide, and CDR3 of the TCR  chain has interactions extending from P5 to P8. However, this orientation appears to differ from the model proposed by Jorgensen et al. (6), in which the TCR is rotated approximately 90°relative to the peptide-MHC surface. Thus far, no crystal structure of trimolecular complex, including class II molecules, has been determined, and it is unclear whether formation of the trimolecular complex is predicted by a general model demonstrated with a MHC class I molecule or is determined individually by each of the component...